Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2008
12/31/2008WO2009000413A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
12/31/2008WO2009000412A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
12/31/2008WO2009000087A1 Substituted fused pyrimidines as antagonists of gpr105 activity
12/31/2008WO2008133669A3 Viral inhibitors
12/31/2008WO2008127399A3 Azaindole derivatives as cftr modulators
12/31/2008WO2008126034A3 Oxazolidinone antibiotics
12/31/2008WO2008123796A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
12/31/2008WO2008117269A3 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
12/31/2008WO2008082487A3 Novel jnk inhibitors
12/31/2008WO2008008359A3 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor
12/31/2008WO2006041900A9 SUBSTITUTED N-ARYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS
12/31/2008WO2006041900A8 SUBSTITUTED N-ARYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS
12/31/2008EP2009012A1 Novel compound having heterocyclic ring
12/31/2008EP2009005A1 Azolecarboxamide derivative
12/31/2008EP2009002A1 New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
12/31/2008EP2007857A1 Use of rylenes as markers for liquids
12/31/2008EP2007765A2 Immunopotentiating compounds
12/31/2008EP2007764A1 Process for the preparation of cgrp antagonist
12/31/2008EP2007763A2 Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
12/31/2008EP2007762A2 Mono and di-substituted oxycodone compounds and compositions
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007723A2 Organic compounds
12/31/2008EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
12/31/2008EP1732926B1 Mitotic kinesin inhibitors
12/31/2008EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors
12/31/2008EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
12/31/2008CN101336243A Lactam compounds and methods of using the same
12/31/2008CN101336242A Improved method of preparation for imidazolepyridines
12/31/2008CN100447142C Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
12/31/2008CN100447141C Hetero-bicyclic crf antagonists
12/31/2008CN100447140C 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
12/31/2008CA2693142A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
12/31/2008CA2692182A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
12/31/2008CA2691932A1 Use of compounds for preparing anti-tuberculosis agents
12/31/2008CA2691888A1 New chemical compounds
12/31/2008CA2691857A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
12/31/2008CA2691010A1 Substituted fused pyrimidines as antagonists of gpr105 activity
12/31/2008CA2690782A1 Compositions and methods for treatment of cancer
12/31/2008CA2690737A1 6.5-pyrrolopiperidine tachykinin receptor antagonists
12/31/2008CA2690192A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
12/31/2008CA2689945A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors
12/31/2008CA2686224A1 Piperazine compounds having herbicidal action
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470797 Nuclear hormone receptor modulator; anticarcinogenic agent; 3-(4-Cyano-3-trifluoromethylphenylcarbamoyl containing 3-carboxy-14-dimethyl-5-oxa-7-oxybicyclo(2.2.2) heptane compound
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008US7470712 Amino-benzazoles as P2Y1 receptor inhibitors
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470709 Benzimidazole quinolinones and uses thereof
12/30/2008US7470706 Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
12/30/2008US7470705 e.g. Cis-4-[acety1-(3,5-bis-trifluoromethyl-benzyl)-amino]-2-ethyl-6-methoxy-3,4-dihydro-2H- [1,5]naphthyridine-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis
12/30/2008US7470704 Benzonaphthyridines
12/30/2008US7470703 Yohimbine derivatives and use thereof
12/30/2008US7470698 Adenosine A3 receptor modulators
12/30/2008US7470696 Tyrosine kinase inhibitors
12/30/2008US7470693 Oxalamide derivatives as kinase inhibitors
12/30/2008US7470691 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/30/2008US7470690 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder
12/30/2008US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/25/2008US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta
12/25/2008US20080319005 Phenylacetamides Suitable as Protein Kinase Inhibitors
12/25/2008US20080319003 Cyclic amine compound and pest control agent
12/25/2008US20080318999 Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators
12/25/2008US20080318997 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
12/25/2008US20080318991 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/25/2008US20080318990 Spiroindolines as modulators of chemokine receptors
12/25/2008US20080318979 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
12/25/2008US20080318978 Hyperaldosteronism; 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]phyridin-5-yl)cyclohexanecarbonitrile; 1-[3-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-8-yl)pyrrolidin-1-yl]ethanone
12/25/2008US20080318977 Condensed Pyridines as Kinase Inhibitors
12/25/2008US20080318966 Sinomenine Derivatives and Preparation and Uses Thereof
12/25/2008US20080318962 Fungicides Based on Nitrogen-Containing Heterocycles
12/25/2008US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080318947 Inhibitors of Akt Activity
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318943 Compounds and Uses Thereof - 848
12/25/2008US20080318940 Quinazolinone Derivatives as Vanilloid Antagonists
12/25/2008US20080318935 Substituted imidazoheterocycles
12/25/2008US20080318927 Substituted monocyclic CGRP receptor antagonists
12/25/2008US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle
12/25/2008US20080314655 Steering and Driving System for an Industrial Truck
12/25/2008US20080314285 A mixture of diketopyrrolopyrrole dyes, dispersants and a quinacridone derivative containing acid groups or salts; inkjet inks; high dispersion quality and stability
12/24/2008WO2008157752A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/24/2008WO2008157404A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008155745A2 New process for the manufacture of 1h-imidazo[4,5-c]-quinoline ring systems
12/24/2008WO2008155468A1 Activators and therapeutic applications thereof
12/24/2008WO2008155441A1 Activators and therapeutic applications thereof
12/24/2008WO2008155421A2 Indolin-2-ones and aza-indolin-2-ones
12/24/2008WO2008155000A1 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives
12/24/2008WO2008125578A3 A method for the preparation of mirtazapine
12/24/2008WO2008121261A3 Prodrugs of triciribin suitable for treatment of tumors and cancer
12/24/2008WO2008086014A3 Bis-aryl amide derivatives useful for the treatment of cancer
12/24/2008WO2008060476A3 Nitrogen-containing heterocyclic compounds and methods of use thereof
12/24/2008WO2008057856A3 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
12/24/2008WO2008048866A3 Bicyclic heteroaromatic compounds
12/24/2008WO2006102610A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 646